Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group

High Cost Drugs

Click here to download the Kent and Medway Health Economy National Tariff Excluded Drugs Manual
Also known as the High Cost Drugs (HCD) Manual. Last updated: Oct 2024

The purpose of this manual is to describe the process for funding high cost drugs or devices excluded from the National Tariff payment system, (previously known as National Tariff Exclusions). These drugs or devices are only commissioned for those indications listed under the individual drug. With regard to items commissioned by ICB, drugs or devices may not be commissioned across every ICB.

Drugs or devices may not be commissioned across every ICB. Information on whether a ICB has commissioned a drug can be found in the “Commissioner” column in the manual. Blueteq forms must be completed in all cases. Invoices will be refused for indications not listed within this manual.

If a drug is being requested to treat a patient for an indication/condition NOT listed in the manual then an Individual Funding Request (IFR) or Business Case must be made to either the ICB or NHS England depending on who currently commissions the drug for other uses. IFR requests may be made for rare diseases or exceptional circumstances. A business case would be required where it is expected or foreseeable that there is a cohort of patients affected. Please contact the named individual at the front of the manual (link above) for preliminary advice on whether an IFR or business case is required.

The tables below contain a summary of the high cost drugs, for full details please see the entries within the ICB manual and NHSE manual.

Drug Name Indication Commissioner
3,4-DIAMINOPYRIDINE LAMBERT-EATON MYASTHENIC SYNDROME (LEMS) NHS ENGLAND
ABACAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
ABALOPARATIDE MALE AND JUVENILE OSTEOPOROSIS
HYPOPARATHYROIDISM
NHS ENGLAND
Abaloparatide (Eladynos®) Osteoporosis ICB
ABATACEPT JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ABATACEPT JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ABATACEPT REFRACTORY IDIOPATHIC INFLAMMATORY MYOPATHIES NHS ENGLAND
ABATACEPT SEVERE TREATMENT-RESISTANT MORPHOEA (LOCALISED SCLERODERMA) NHS ENGLAND
Abatacept (Orencia®) Rheumatoid arthritis (1st line biologic ) ICB
Abatacept (Orencia®) Rheumatoid Arthritis (2nd line biologic) ICB
Abatacept (Orencia®) Juvenile Idiopathic arthritis (adult only)  ICB
ABEMACICLIB CANCER
Breast cancer
NHS ENGLAND
ABEMACICLIB CANCER
Breast cancer
NHS ENGLAND
ABEMACICLIB CANCER
Breast cancer
NHS ENGLAND
ABIRATERONE CANCER
Prostate cancer
NHS ENGLAND
ABIRATERONE CANCER
Prostate cancer
NHS ENGLAND
ABIRATERONE CANCER
Prostate cancer
NHS ENGLAND
ABIRATERONE CANCER
Prostate cancer
NHS ENGLAND
ABIRATERONE CANCER
Prostate cancer
NHS ENGLAND
ABROCITINIB MODERATE TO SEVERE ATOPIC DERMATITIS - PAEDIATRICS NHS ENGLAND
Abrocitinib (Cibinqo®) Moderate to severe atopic dermatitis ICB
ACALABRUTINIB CANCER
CLL
NHS ENGLAND
ACORAMIDIS AMYLOIDOSIS NHS ENGLAND
ADALIMUMAB BEHCETS SYNDROME NHS ENGLAND
ADALIMUMAB HIDRADENITIS SUPPURATIVA NHS ENGLAND
ADALIMUMAB JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ADALIMUMAB JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ADALIMUMAB NON BACTERIAL OSTEOMYELITIS/OSTEITIS NHS ENGLAND
ADALIMUMAB PLAQUE PSORIASIS - PAEDIATRICS NHS ENGLAND
ADALIMUMAB UVEITIS - ADULTS NHS ENGLAND
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Ankylosing Spondylitis and Axial Spondyloarthritis  ICB
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Chrohn’s Disease(1st and 2nd line biologic) ICB
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Psoriasis ICB
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Psoriatic Arthritis ICB
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Rheumatoid arthritis (1st line biologic ) ICB
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Rheumatoid Arthritis (2nd line biologic) ICB
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Juvenile idiopathic arthritis (adult) ICB
Adalimumab (Humira®, Imraldi®, Amgevita®, Yuflyma®) Ulcerative Colitis (moderate to severe) ICB
ADUCANUMAB ALZHEIMERS DISEASE - YOUNG ONSET DEMENTIA NHS ENGLAND
AFAMELANOTIDE ERYTHROPOIETIC PROTOPORPHYRIA NHS ENGLAND
AFAMITRESGENE AUTOLEUCEL CANCER
Sarcoma
NHS ENGLAND
AFATINIB CANCER
Lung cancer
NHS ENGLAND
AFLIBERCEPT CANCER
Colorectal cancer
NHS ENGLAND
Aflibercept (Eylea®) Macular degeneration(wet age-related) ICB
Aflibercept (Eylea®) Diabetic macular oedema ICB
Aflibercept (Eylea®) Choroidal Neovascularisation ICB
Aflibercept (Eylea®) Macular Oedema after BRVO(Branch Retinal Vein Occlusion) ICB
Aflibercept (Eylea®) Macular Oedema secondary to central retinal vein occlusion ICB
AGALSIDASE ALFA FABRY'S DISEASE NHS ENGLAND
AGALSIDASE BETA FABRY'S DISEASE NHS ENGLAND
ALBUTREPENONACOG ALFA
(FACTOR IX - recombinant) 
HAEMOPHILIA B NHS ENGLAND
ALDESLEUKIN CANCER   NHS ENGLAND
ALECTINIB CANCER
Lung cancer
NHS ENGLAND
ALECTINIB CANCER
Lung cancer
CDF
ALECTINIB CANCER
Lung cancer
NHS ENGLAND
ALEMTUZUMAB BEHCETS SYNDROME NHS ENGLAND
ALEMTUZUMAB CANCER
CLL
NHS ENGLAND
ALEMTUZUMAB MULTIPLE SCLEROSIS NHS ENGLAND
ALEMTUZUMAB MULTIPLE SCLEROSIS NHS ENGLAND
ALEMTUZUMAB PRE-TRANSPLANT IMMUNOSUPPRESSION NHS ENGLAND
ALGLUCOSIDASE ALFA POMPE DISEASE NHS ENGLAND
Alirocumab (Praluent®) Primary hypercholesterolaemia or mixed dyslipidaemia ICB
Alirocumab (Praluent®) Primary heterozygous-familial hypercholesterolaemia ICB
Alitretinoin (Toctino®) Eczema (chronic) ICB
ALPELISIB CANCER
CML
NHS ENGLAND
AMBRISENTAN PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
AMIFAMPRIDINE PHOSPHATE LAMBERT-EATON MYASTHENIC SYNDROME (LEMS) NHS ENGLAND
AMIKACIN INHALATION CYSTIC FIBROSIS NHS ENGLAND
AMIKACIN LIPOSOMAL (INHALED) CYSTIC FIBROSIS NHS ENGLAND
AMIKACIN LIPOSOMAL (INHALED) NON-TUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE DUE TO MYCOBACTERIUM AVIUM COMPLEX (MAC) NHS ENGLAND
AMIVANTAMAB CANCER NHS ENGLAND
AMPHOTERICIN LIPOSOMAL FUNGAL INFECTION NHS ENGLAND
ANAKINRA ADULT ONSET STILL'S DISEASE NHS ENGLAND
ANAKINRA CASTLEMAN'S DISEASE NHS ENGLAND
ANAKINRA CRYOPYRIN ASSOCIATED PERIODIC SYNDROME NHS ENGLAND
ANAKINRA HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) NHS ENGLAND
ANAKINRA JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ANAKINRA JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ANAKINRA PERIODIC FEVERS AND AUTOINFLAMMATORY CONDITIONS NHS ENGLAND
Andexanet alfa (Andexxa®) Anticoagulation reversal from apixaban or rivaroxaban ICB
ANIDULAFUNGIN FUNGAL INFECTION NHS ENGLAND
ANIFROLUMAB SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NHS ENGLAND
ANTILYMPHOCYTE GLOBULIN  APLASTIC ANAEMIA
ORGAN TRANSPLANT
NHS ENGLAND
ANTITHROMBIN III AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
ANTITHYMOCYTE IMMUNOGLOBULIN APLASTIC ANAEMIA
ORGAN TRANSPLANT
NHS ENGLAND
APADAMTASE ALFA THROMBOTIC THROMBOCYTOPENIC PURPURA  NHS ENGLAND
APALUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
APALUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
Apremilast (Otezla®) Psoriatic Arthritis ICB
Apremilast (Otezla®) Moderate to severe plaque psoriasis ICB
ARIMOCLOMOL NIEMANN-PICK DISEASE NHS ENGLAND
ARSENIC TRIOXIDE CANCER
APML
NHS ENGLAND
ARSENIC TRIOXIDE CANCER
APML (high risk)
NHS ENGLAND
ASCIMINIB CANCER
CML
NHS ENGLAND
ASFOTASE ALFA HYPOPHOSPHATASIA NHS ENGLAND
ATACICEPT SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NHS ENGLAND
ATALUREN DUCHENNE MUSCULAR DYSTROPHY NHS ENGLAND
ATAZANAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS  NHS ENGLAND
ATEZOLIZUMAB CANCER
Breast cancer
NHS ENGLAND
ATEZOLIZUMAB CANCER
Hepatocellular carcinoma
NHS ENGLAND
ATEZOLIZUMAB CANCER
Lung cancer
NHS ENGLAND
ATEZOLIZUMAB CANCER
Lung cancer
NHS ENGLAND
ATEZOLIZUMAB CANCER
Lung cancer
NHS ENGLAND
ATEZOLIZUMAB CANCER
Lung cancer
NHS ENGLAND
ATEZOLIZUMAB CANCER
Lung cancer
CDF
ATEZOLIZUMAB CANCER
Urothelial cancer
NHS ENGLAND
ATEZOLIZUMAB CANCER
Urothelial carcinoma
NHS ENGLAND
ATIDARSAGENE AUTOTEMCEL METACHROMATIC LEUKODYSTROPHY (MLD) NHS ENGLAND
Atogepant (Aquipta®) preventing migraine ICB
AUTOLOGOUS & ALLOGENIC SERUM EYE DROPS SEVERE OCULAR SURFACE DISEASE NHS ENGLAND
AUTOLOGOUS ANTI-CD19-TRANSDUCED CD3+ CELLS - KTE-X19 CANCER
Mantle cell lymphoma
CDF
AUTOLOGOUS HUMAN CHONDROCYTE IMPLANTATION ARTICULAR CARTILAGE DEFECT NHS ENGLAND
AUTOLOGOUS HUMAN CHONDROCYTE IMPLANTATION ARTICULAR CARTILAGE DEFECT NHS ENGLAND
AUTOLOGOUS LENTIVIRAL WAS STEM CELL THERAPY PRIMARY IMMUNODEFICIENCY - WISKOTT ALDRICH SYNDROME NHS ENGLAND
AVACOPAN GRANULOMATOSIS NHS ENGLAND
AVALGLUCOSIDASE ALFA GLYCOGEN STORAGE DISEASE TYPE II (POMPE DISEASE) NHS ENGLAND
AVALOTCAGENE ONTAPRVOVEC ORNITHINE CARBAMOYL TRANSFERASE DEFICIENCY NHS ENGLAND
AVAPRITINIB CANCER
Gastrointestinal stromal tumour
NHS ENGLAND
AVAPRITINIB CANCER
Mastocytosis
CDF
AVAPRITINIB CANCER
Mastocytosis
NHS ENGLAND
Avatrombopag (Doptelet®) Primary chronic immune thrombocytopenia ICB
Avatrombopag (Doptelet®) Thrombocytopenia in people with chronic liver disease ICB
AVELUMAB CANCER
Merkel cell carcinoma
NHS ENGLAND
AVELUMAB CANCER
Merkel cell carcinoma
NHS ENGLAND
AVELUMAB CANCER
Renal cell carcinoma
CDF
AVELUMAB CANCER
Urothelial cancer
NHS ENGLAND
AXICABTAGENE CILOLEUCEL  CANCER
B-cell lymphoma
CDF
AXICABTAGENE CILOLEUCEL  CANCER
B-cell lymphoma
NHS ENGLAND
AXITINIB CANCER
Renal cell carcinoma
NHS ENGLAND
AZACITIDINE CANCER
AML
NHS ENGLAND
AZACITIDINE CANCER
AML
NHS ENGLAND
AZACITIDINE CANCER
CMML / AML
NHS ENGLAND
AZATHIOPRINE TRANSPLANT IMMUNOSUPPRESSION ONLY NHS ENGLAND
AZTREONAM LYSINE CYSTIC FIBROSIS NHS ENGLAND
AZTREONAM LYSINE CYSTIC FIBROSIS (CONTINUOUS TREATMENT) NHS ENGLAND
BARDOXOLONE METHYL CKD CAUSED BY ALPORT SYNDROME NHS ENGLAND
BARICITINIB MONOGENIC INTERFERONOPATHIES NHS ENGLAND
Baricitinib (Olumiant®) Moderate to severe atopic dermatitis ICB
Baricitinib (Olumiant®) Rheumatoid Arthritis ICB
BASILIXIMAB KIDNEY TRANSPLANT - ADULTS NHS ENGLAND
BASILIXIMAB KIDNEY TRANSPLANT - CHILDREN & YOUNG PEOPLE NHS ENGLAND
BECLABUVIR HEPATITIS C NHS ENGLAND
BEDAQUILINE TB NHS ENGLAND
BEDAQUILINE TB NHS ENGLAND
BEGELOMAB GRAFT VERSUS HOST DISEASE NHS ENGLAND
BELANTAMAB MAFODOTIN CANCER
MM
NHS ENGLAND
BELATACEPT KIDNEY TRANSPLANT - ADULTS NHS ENGLAND
BELATACEPT KIDNEY TRANSPLANT - CHILDREN & YOUNG PEOPLE NHS ENGLAND
BELIMUMAB SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NHS ENGLAND
BELUMOSUDIL GRAFT VERSUS HOST DISEASE NHS ENGLAND
BELUMOSUDIL GRAFT VERSUS HOST DISEASE NHS ENGLAND
BELZUTIFAN CANCER NHS ENGLAND
BELZUTIFAN CANCER
Tumours associated with von Hippel-Lindau disease
CDF
BENDAMUSTINE CANCER
CLL
NHS ENGLAND
BENDAMUSTINE CANCER
Follicular lymphoma
NHS ENGLAND
BENDAMUSTINE CANCER
HL
NHS ENGLAND
BENDAMUSTINE CANCER
MCL
NHS ENGLAND
BENDAMUSTINE CANCER
MCL
NHS ENGLAND
BENDAMUSTINE CANCER
MM
NHS ENGLAND
BENDAMUSTINE CANCER
NHL
NHS ENGLAND
BENRALIZUMAB ASTHMA NHS ENGLAND
BEROTRALSTAT HEREDITARY ANGIOEDEMA - PROPHYLACTIC TREATMENT NHS ENGLAND
BETAINE HOMOCYSTINURIA NHS ENGLAND
BEVACIZUMAB CANCER
Cervical cancer
NHS ENGLAND
BEVACIZUMAB CANCER
Colorectal cancer
NHS ENGLAND
BEVACIZUMAB CANCER
Colorectal cancer
NHS ENGLAND
BEVACIZUMAB CANCER
Colorectal cancer
NHS ENGLAND
BEVACIZUMAB CANCER
Lung cancer
NHS ENGLAND
BEVACIZUMAB CANCER
Ovarian, fallopian tube and peritoneal cancer
NHS ENGLAND
BEVACIZUMAB NEUROFIBROMATOSIS NHS ENGLAND
Bevacizumab  (Avastin®) Choroidal neovascularisation (CNV) due to causes other than age-related macular degeneration (AMD) or pathological myopia (PM) ICB
BICTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
BICTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
BIMAGRUMAB INCLUSION BODY MYOSITIS NHS ENGLAND
Bimekizumab (Bimzelx®) Psoriatic Arthritis ICB
Bimekizumab (Bimzelx®) Axial spondyloarthritis ICB
Bimekizumab (Bimzelx®) Psoriasis ICB
BINIMETINIB CANCER
Melanoma
NHS ENGLAND
BIOTIN MULTIPLE SCLEROSIS NHS ENGLAND
BIRCH BARK EXTRACT EPIDERMOLYSIS BULLOSA NHS ENGLAND
BIS-CHOLINE TETRATHIOMOLYBDATE WILSON'S DISEASE NHS ENGLAND
BIZALIMOGENE RALAPLASMID CERVICAL DYSPLASIA NHS ENGLAND
BLINATUMOMAB CANCER
ALL
NHS ENGLAND
BLINATUMOMAB CANCER
ALL
NHS ENGLAND
BORTEZOMIB CANCER
Amyloid light-chain amyloidosis
NHS ENGLAND
BORTEZOMIB CANCER
MM
NHS ENGLAND
BORTEZOMIB CANCER
MCL
NHS ENGLAND
BORTEZOMIB CANCER
MCL
NHS ENGLAND
BORTEZOMIB CANCER
MM
NHS ENGLAND
BORTEZOMIB CANCER
MM
NHS ENGLAND
BORTEZOMIB CANCER
MM
NHS ENGLAND
BORTEZOMIB CANCER
MM
CDF
BORTEZOMIB CANCER
MM
NHS ENGLAND
BORTEZOMIB CANCER
Waldenstrom's macroglobulinaemia
NHS ENGLAND
BORTEZOMIB ORGAN REJECTION POST KIDNEY TRANSPLANT NHS ENGLAND
BOSENTAN DIGITAL ULCERS NHS ENGLAND
BOSENTAN PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
BOSUTINIB CANCER
CML
NHS ENGLAND
BOTARETIGENE SPAROPARVOVEC RETINAL DISORDERS NHS ENGLAND
BRAIN CANCER VACCINE CANCER NHS ENGLAND
BRENTUXIMAB CANCER
HL
NHS ENGLAND
BRENTUXIMAB CANCER
Lymphoma
NHS ENGLAND
BRENTUXIMAB CANCER
Lymphoma
NHS ENGLAND
BRENTUXIMAB CANCER
Lymphoma
NHS ENGLAND
BREXUCABTAGENE AUTOLEUCEL CANCER
ALL
CDF
BRIGATINIB CANCER
Lung cancer
NHS ENGLAND
BRIGATINIB CANCER
Lung cancer
NHS ENGLAND
BRIMAPITIDE ACUTE SENSORINEURAL HEARING LOSS NHS ENGLAND
Brodalumab (Kyntheum®) Moderate to severe plaque psoriasis ICB
Brolucizumab (Beovu®) Diabetic macular oedema ICB
Brolucizumab (Beovu®) Macular degeneration(wet age-related) ICB
BULEVIRTIDE COMPENSATED LIVER DISEASE  NHS ENGLAND
BUROSUMAB X LINKED HYPOPHOSPHATAEMIA NHS ENGLAND
BUROSUMAB X LINKED HYPOPHOSPHATAEMIA NHS ENGLAND
C1 ESTERASE INHIBITORS HEREDITARY ANGIOEDEMA - ACUTE TREATMENT  NHS ENGLAND
C1 ESTERASE INHIBITORS HEREDITARY ANGIOEDEMA - PROPHYLACTIC TREATMENT NHS ENGLAND
C1 ESTERASE INHIBITORS HEREDITARY ANGIOEDEMA - PROPHYLACTIC TREATMENT IN CHILDREN (CINRYZE ONLY) NHS ENGLAND
CABAZITAXEL CANCER
Prostate cancer
NHS ENGLAND
CABOTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
CABOTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
CABOZANTINIB CANCER
Thyroid cancer
NHS ENGLAND
CABOZANTINIB CANCER
Hepatocellular cancer
NHS ENGLAND
CABOZANTINIB CANCER
Renal cell carcinoma
NHS ENGLAND
CABOZANTINIB CANCER
Renal cell carcinoma
NHS ENGLAND
CABOZANTINIB CANCER
Renal cell carcinoma
NHS ENGLAND
CALCIFEDIOL HYPERPARATHYROIDISM IN RENAL DIALYSIS PATIENTS NHS ENGLAND
CALCIUM, MAGNESIUM, POTASSIUM + SODIUM OXYBATE NARCOLEPSY - PAEDIATRICS NHS ENGLAND
CANAKINUMAB CRYOPYRIN ASSOCIATED PERIODIC SYNDROME NHS ENGLAND
CANAKINUMAB JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
CANAKINUMAB PERIODIC FEVER SYNDROMES: TRAPS, HIDS/MKD and FMF NHS ENGLAND
CANAKINUMAB STILL'S DISEASE NHS ENGLAND
CANNABIDIOL DRAVET SYNDROME NHS ENGLAND
CANNABIDIOL LENNOX-GASTAUT SYNDROME NHS ENGLAND
CANNABIDIOL TUBEROUS SCLEROSIS SYNDROME NHS ENGLAND
CANPULDENCEL-T CANCER
Glioblastoma
NHS ENGLAND
CAPLACIZUMAB THROMBOTIC THROMBOCYTOPENIC PURPURA  NHS ENGLAND
CAPMATINIB CANCER
Lung cancer
NHS ENGLAND
CARFILZOMIB CANCER
MM
NHS ENGLAND
CARFILZOMIB CANCER
MM
NHS ENGLAND
CARGLUMIC ACID UREA CYCLE DISORDERS NHS ENGLAND
CARNITINE CARNITINE DEFICIENCY NHS ENGLAND
CASPOFUNGIN FUNGAL INFECTION NHS ENGLAND
CATRIDECACOG
(FACTOR XIII - recombinant)
AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
CEMIPLIMAB CANCER
Skin cancer
NHS ENGLAND
CEMIPLIMAB CANCER
Cervical cancer
NHS ENGLAND
CENEGERMIN NEUROTROPHIC KERATITIS NHS ENGLAND
CERITINIB CANCER
Lung cancer
NHS ENGLAND
CERITINIB CANCER
Lung cancer
NHS ENGLAND
CERLIPONASE ALFA NEURONAL CEROID LIPOFUSCINOSIS NHS ENGLAND
Certolizumab pegol (Cimzia®) Rheumatoid Arthritis ICB
Certolizumab pegol (Cimzia®) Moderate to severe plaque psoriasis ICB
Certolizumab pegol (Cimzia®) Psoriatic Arthritis ICB
Certolizumab pegol (Cimzia®) Ankylosing Spondylitis and Axial Spondyloarthritis  ICB
CETUXIMAB CANCER
Colorectal cancer
NHS ENGLAND
CETUXIMAB CANCER
Colorectal cancer
NHS ENGLAND
CETUXIMAB CANCER
Head and neck cancer
NHS ENGLAND
CETUXIMAB CANCER
Head and neck cancer
NHS ENGLAND
CHEMOTHERAPY CANCER (NOT SPECIFICALLY LISTED) NHS ENGLAND
CDF
CHENODEOXYCHOLIC ACID CEREBROTENDINOUS XANTHOMATOSIS (CTX)  NHS ENGLAND
CHENODEOXYCHOLIC ACID PRIMARY BILIARY CIRRHOSIS NHS ENGLAND
CHLORMETHINE MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA NHS ENGLAND
CHOLIC ACID INBORN ERRORS IN PRIMARY BILE ACID SYNTHESIS NHS ENGLAND
CICLOSPORIN TRANSPLANT IMMUNOSUPPRESSION ONLY NHS ENGLAND
CILTACABTAGENE AUTOLEUCEL CANCER
MM
NHS ENGLAND
CIPAGLUCOSIDASE ALFA GLYCOGEN STORAGE DISEASE TYPE II (POMPE DISEASE) NHS ENGLAND
CIPROFLOXACIN  INHALATION CYSTIC FIBROSIS NHS ENGLAND
CIPROFLOXACIN LIPOSOMAL (INHALED) CYSTIC FIBROSIS NHS ENGLAND
CLADRIBINE MULTIPLE SCLEROSIS NHS ENGLAND
CLADRIBINE PULMONARY LANGERHANS HISTIOCYTOSIS NHS ENGLAND
CLOFARABINE CANCER
ALL
NHS ENGLAND
CLOFARABINE CANCER
AML
NHS ENGLAND
COBICISTAT HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
COBICISTAT HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
COBICISTAT HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
COBIMETINIB CANCER
Melanoma
NHS ENGLAND
COLESTILAN ADULT RENAL DIALYSIS ONLY NHS ENGLAND
COLISTIMETHATE SODIUM  CYSTIC FIBROSIS NHS ENGLAND
COLISTIMETHATE SODIUM  CYSTIC FIBROSIS NHS ENGLAND
Collagenase clostridium hystoliticum (Xiapex®) Dupuytren’s contracture in patients with a palpable cord ICB
CONCIZUMAB PREVENTION OF BLEEDING EPISODES IN HAEMOPHILIA A OR B NHS ENGLAND
CONESTAT ALFA HEREDITARY ANGIOEDEMA - ACUTE TREATMENT ONLY NHS ENGLAND
COPPER HISTIDINATE MENKES DISEASE NHS ENGLAND
CRIZOTINIB CANCER
Lung cancer
NHS ENGLAND
CRIZOTINIB CANCER
Lung cancer
NHS ENGLAND
CRIZOTINIB CANCER
Lung cancer
NHS ENGLAND
CROVALIMAB PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA NHS ENGLAND
CYSTEAMINE (MERCAPTAMINE) NEPHROPATHIC CYSTINOSIS NHS ENGLAND
DABRAFENIB CANCER
Glioma
NHS ENGLAND
DABRAFENIB CANCER
Lung cancer
NHS ENGLAND
DABRAFENIB CANCER
Melanoma
NHS ENGLAND
DABRAFENIB CANCER
Melanoma
NHS ENGLAND
DABRAFENIB CANCER
Melanoma
NHS ENGLAND
DABRAFENIB CANCER
Thyroid cancer
NHS ENGLAND
DACOMITINIB CANCER
Lung cancer
NHS ENGLAND
DAMOCTOCOG ALFA PEGOL
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
DANICOPAN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA NHS ENGLAND
DARATUMUMAB CANCER
Amyloid light-chain amyloidosis
NHS ENGLAND
DARATUMUMAB CANCER
MM
NHS ENGLAND
DARATUMUMAB CANCER
MM
NHS ENGLAND
DARATUMUMAB CANCER
MM
NHS ENGLAND
DARATUMUMAB CANCER
MM
NHS ENGLAND
DARBEPOETIN ALPHA DIALYSIS-INDUCED ANAEMIA NHS ENGLAND
DAROLUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
DAROLUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
DARUNAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS  NHS ENGLAND
DASABUVIR HEPATITIS C NHS ENGLAND
DASATINIB CANCER
CML
NHS ENGLAND
DASATINIB CANCER
CML
NHS ENGLAND
DECITABINE CANCER
AML
NHS ENGLAND
DEFERASIROX IRON CHELATION IN THALASSAEMIA AND SICKLE CELL NHS ENGLAND
DEFERASIROX IRON CHELATION IN THALASSAEMIA AND SICKLE CELL NHS ENGLAND
DEFERIPRONE IRON CHELATION IN THALASSAEMIA AND SICKLE CELL NHS ENGLAND
DEFERIPRONE IRON CHELATION IN THALASSAEMIA AND SICKLE CELL NHS ENGLAND
DEFIBROTIDE HEPATIC VENO-OCCLUSIVE DISEASE NHS ENGLAND
DELAMANID TB NHS ENGLAND
DELANDISTROGENE MOXAPARVOVEC DUCHENNE MUSCULAR DYSTROPHY NHS ENGLAND
DESFERRIOXAMINE IRON CHELATION IN THALASSAEMIA AND SICKLE CELL NHS ENGLAND
DESFERRIOXAMINE IRON CHELATION IN THALASSAEMIA AND SICKLE CELL NHS ENGLAND
Deucravacitinib (Sotyktu®) Psoriasis ICB
DEXAMETHASONE  INTRA-ERYTHROCYTE ATAXIA TELANGIECTASIA NHS ENGLAND
Dexamethasone intravitreal implant (Ozurdex®) Macular oedema (retinal vein occlusion) ICB
Dexamethasone intravitreal implant (Ozurdex®) Non-infections uveitis ICB
Dexamethasone intravitreal implant (Ozurdex®) Diabetic macular oedema ICB
DEXRAZOXANE ANTHRACYCLINE CARDIOTOXICITY NHS ENGLAND
DEXRAZOXANE ANTHRACYCLINE EXTRAVASATION NHS ENGLAND
DIBOTERMIN ALFA COMPLEX SPINAL SURGERY NHS ENGLAND
DIDANOSINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
DIFELIKEFALIN PRURITUS ASSOCIATED WITH CHRONIC KIDNEY DISEASE ON HAEMODIALYSIS NHS ENGLAND
Digoxin immune fab (DigiFab®) Digoxin toxicity This drug has not been formally commissioned, however due the nature of the indication it is considered that all CCGs would fund.
DIMETHYL FUMARATE MULTIPLE SCLEROSIS NHS ENGLAND
Dimethyl Fumarate (Skilarence) Moderate to severe plaque psoriasis ICB
DINUTUXIMAB BETA CANCER
Neuroblastoma
NHS ENGLAND
DIRLOCOCTOGENE SAMOPARVOVEC HAEMOPHILIA A NHS ENGLAND
DIROXIMEL FUMARATE MULTIPLE SCLEROSIS NHS ENGLAND
DOCETAXEL CANCER
Prostate cancer
NHS ENGLAND
DOLUTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
DOLUTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
DOLUTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
DOLUTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
DORAVIRINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
DORAVIRINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
DORNASE ALFA CYSTIC FIBROSIS NHS ENGLAND
DORNASE ALFA PRIMARY CILIARY DYSKINESIA NHS ENGLAND
DOSTARLIMAB CANCER
Endometrial cancer
CDF
DOSTARLIMAB CANCER
Endometrial cancer
CDF
DRUG NAME INDICATION COMMISSIONER
DUPILUMAB ASTHMA NHS ENGLAND
Dupilumab (Dupixent®) Moderate to severe atopic dermatitis after topical treatments ICB
DURVALUMAB CANCER
Lung cancer
NHS ENGLAND
DURVALUMAB CANCER
Lung cancer
CDF
DURVALUMAB CANCER
Biliary tract cancer
NHS ENGLAND
DUVELISIB CANCER
CLL
NHS ENGLAND
DUVELISIB CANCER
Follicular lymphoma
NHS ENGLAND
ECALLANTIDE HEREDITARY ANGIOEDEMA - ACUTE TREATMENT ONLY NHS ENGLAND
ECULIZUMAB AHUS NHS ENGLAND
ECULIZUMAB C3 GLOMERULOPATHY  (POST TRANSPLANT) NHS ENGLAND
ECULIZUMAB DELAYED HAEMOLYTIC TRANSFUSION REACTIONS AND HYPERHAEMOLYSIS IN PATIENTS WITH HAEMOGLOBINOPATHIES NHS ENGLAND
ECULIZUMAB NEUROMYELITIS OPTICA NHS ENGLAND
ECULIZUMAB ORGAN REJECTION POST KIDNEY TRANSPLANT NHS ENGLAND
ECULIZUMAB PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA NHS ENGLAND
EFANESOCTOCOG ALFA HAEMOPHILIA A NHS ENGLAND
EFAVIRENZ HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
EFGARTIGIMOD ALFA MYASTHENIA GRAVIS NHS ENGLAND
EFMOROCTOCOG ALFA (EFRALOCTOCOG ALFA)
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
EFRALOCTOCOG ALFA (see EFMOROCTOCOG ALFA)
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
EFRENONACOG ALFA (see EFTRENONACOG ALFA)
(FACTOR IX - recombinant)
HAEMOPHILIA B NHS ENGLAND
EFTRENONACOG ALFA (EFRENONACOG ALFA)
(FACTOR IX - recombinant) 
HAEMOPHILIA B NHS ENGLAND
ELACESTRANT CANCER
Breast cancer
CDF
ELADOCAGENE EXUPARVOVEC AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY NHS ENGLAND
ELAFIBRANOR PRIMARY BILIARY CHOLANGITIS IMF
ELAFIBRANOR PRIMARY BILIARY CHOLANGITIS NHS ENGLAND
ELBASVIR HEPATITIS C NHS ENGLAND
ELEXACAFTOR + TEZACAFTOR + IVACAFTOR CYSTIC FIBROSIS NHS ENGLAND
ELEXACAFTOR + TEZACAFTOR + IVACAFTOR CYSTIC FIBROSIS NHS ENGLAND
ELIGLUSTAT GAUCHER'S DISEASE NHS ENGLAND
ELOSULFASE ALFA MUCOPOLYSACCHARIDOSIS TYPE 4A NHS ENGLAND
ELOTUZUMAB CANCER
MM
NHS ENGLAND
ELRANATAMAB CANCER
MM
CDF
Eltrombopag (Revolade®) Thrombocytopenia purpura ICB
Eltrombopag (Revolade®) Severe aplastic anaemia in adults ICB
ELVITEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
ELVITEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
ELVUCITABINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
EMICIZUMAB HAEMOPHILIA A
with Factor VIII inhibitors
NHS ENGLAND
EMICIZUMAB HAEMOPHILIA A
without Factor VIII inhibitors
NHS ENGLAND
EMIPLACEL MUSCLE INJURY FOLLOWING ARTHROPLASTY NHS ENGLAND
EMIXUSTAT STARGARDT'S DISEASE NHS ENGLAND
EMTRICITABINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
EMTRICITABINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
EMTRICITABINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
EMTRICITABINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
EMTRICITABINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
ENCORAFENIB CANCER
Colorectal cancer
NHS ENGLAND
ENCORAFENIB CANCER
Melanoma
NHS ENGLAND
ENFORTUMAB VEDOTIN CANCER
Urothelial cancer
NHS ENGLAND
ENFUVIRTIDE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
ENTRECTINIB CANCER
Lung cancer
NHS ENGLAND
ENTRECTINIB CANCER
NTRK fusion positive solid tumours
CDF
ENZALUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
ENZALUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
ENZALUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
ENZALUTAMIDE CANCER
Prostate cancer
NHS ENGLAND
EPCORITAMAB CANCER
B-cell lymphoma
NHS ENGLAND
EPLONTERSEN AMYLOIDOSIS NHS ENGLAND
EPOETIN ALPHA, BETA, THETA AND ZETA DIALYSIS-INDUCED ANAEMIA NHS ENGLAND
EPOPROSTENOL DIGITAL ULCERS NHS ENGLAND
EPOPROSTENOL PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
EPRATUZUMAB SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NHS ENGLAND
EPRODISATE AMYLOIDOSIS NHS ENGLAND
EPTACOG ALFA (ACTIVATED)
(FACTOR VIIa - recombinant) 
AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
EPTACOG BETA (ACTIVATED)
(FACTOR VIIa - recombinant) 
AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
Eptinezumab (Vyepti®) Migraine ICB
Erenumab (Aimovig®) Migraine ICB
ERIBULIN CANCER
Breast cancer
NHS ENGLAND
ERLOTINIB CANCER
Lung cancer
NHS ENGLAND
ERLOTINIB CANCER
Lung cancer
NHS ENGLAND
ERLOTINIB CANCER
Lung cancer
NHS ENGLAND
ETANERCEPT JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ETANERCEPT JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
ETANERCEPT BEHCETS SYNDROME NHS ENGLAND
ETANERCEPT PLAQUE PSORIASIS - PAEDIATRICS NHS ENGLAND
Etanercept (Enbrel®, Erelzi®, Benepali®) Ankylosing spondylitis ICB
Etanercept (Enbrel®, Erelzi®, Benepali®) Psoriasis ICB
Etanercept (Enbrel®, Erelzi®, Benepali®) Psoriatic Arthritis ICB
Etanercept (Enbrel®, Erelzi®, Benepali®) Rheumatoid arthritis ICB
Etanercept (Enbrel®, Erelzi®, Benepali®) Juvenile arthritis (adult) ICB
ETEPLIRSEN DUCHENNE MUSCULAR DYSTROPHY NHS ENGLAND
ETRANACOGENE DEZAPARVOVEC HAEMOPHILIA B IMF
ETRASIMOD ULCERATIVE COLITIS - PAEDIATRICS NHS ENGLAND
Etrasimod (Velsipity®) Ulcerative Colitis (moderate to severe) ICB
ETRAVIRINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
EVEROLIMUS CANCER
Breast cancer
NHS ENGLAND
EVEROLIMUS CANCER
NETs
NHS ENGLAND
EVEROLIMUS CANCER
Renal cell carcinoma
NHS ENGLAND
EVEROLIMUS CANCER
Renal cell carcinoma
NHS ENGLAND
EVEROLIMUS KIDNEY TRANSPLANT - ADULTS NHS ENGLAND
EVEROLIMUS KIDNEY TRANSPLANT - CHILDREN & YOUNG PEOPLE NHS ENGLAND
EVEROLIMUS PREVENTING ORGAN REJECTION IN HEART TRANSPLANTATION NHS ENGLAND
EVEROLIMUS PREVENTING ORGAN REJECTION IN LIVER TRANSPLANTATION NHS ENGLAND
EVEROLIMUS RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS NHS ENGLAND
EVEROLIMUS SEIZURES ASSOCIATED WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX NHS ENGLAND
EVEROLIMUS SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX NHS ENGLAND
EVINACUMAB HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA NHS ENGLAND
EVOLOCUMAB HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA NHS ENGLAND
Evolocumab (Repatha SureClick®) Primary hypercholesterolaemia or mixed dyslipidaemia ICB
Evolocumab (Repatha SureClick®) Primary heterozygous-familial hypercholesterolaemia ICB
EXAGAMGLOGENE AUTOTEMCEL SICKLE CELL DISEASE NHS ENGLAND
EXAGAMGLOGENE AUTOTEMCEL THALASSAEMIA IMF
EX-VIVO EXPANDED AUTOLOGOUS HUMAN CORNEAL EPITHELIAL CELLS CONTAINING STEM CELLS TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE LIMBAL STEM CELL DEFICIENCY (LSCD), UNILATERAL OR BILATERAL, DUE TO PHYSICAL OR CHEMICAL OCULAR BURNS NHS ENGLAND
FACTOR IX - see drug names HAEMOPHILIA B NHS ENGLAND
FACTOR VII AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
FACTOR VIIa - see drug names AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
FACTOR VIII - see drug names HAEMOPHILIA A NHS ENGLAND
FACTOR VIII + VON WILLEBRAND FACTOR
(VON WILLEBRAND FACTOR - PLASMA with FVIII)
VON WILLEBRAND DEFICIENCY NHS ENGLAND
FACTOR VIII INHIBITOR BYPASSING FRACTION AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
FACTOR X (see HUMAN COAGULATION FACTOR X)
(FACTOR X - plasma derived)
AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
FACTOR XI AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
FACTOR XIII
(FACTOR XIII - plasma derived)
AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
FAMPRIDINE MULTIPLE SCLEROSIS NHS ENGLAND
Faricimab (Vabysmo®) Macular oedema after RVO ICB
Faricimab (Vabysmo®) Diabetic Macular Oedema ICB
Faricimab (Vabysmo®) Macular degeneration(wet age-related) ICB
FEDRATINIB CANCER
Myelofibrosis
CDF
FEDRATINIB CANCER
Myelofibrosis
NHS ENGLAND
FENFLURAMINE DRAVET SYNDROME NHS ENGLAND
FIBRINOGEN AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
FIDANACOGENE ELAPARVOVEC HAEMOPHILIA B NHS ENGLAND
Fidaxomicin Recurrent Clostridium Difficile Infection ICB
Filgotinib (Jyseleca®) Ulcerative Colitis (moderate to severe) ICB
Filgotinib (Jyseleca®) Moderate to Severe Rheumatoid Arthritis ICB
FINGOLIMOD MULTIPLE SCLEROSIS NHS ENGLAND
FINGOLIMOD MULTIPLE SCLEROSIS NHS ENGLAND
FITUSIRAN HAEMOPHILIA A AND B NHS ENGLAND
Fluocinolone acetonide (Iluvien®) Non-infections uveitis ICB
Fluocinolone acetonide (Iluvien®) Diabetic Macular Oedema ICB
Fomepizole Ethylene glycol poisoning and Methanol poisoning ICB
FORDADISTROGENE MOVAPARVOVEC DUCHENNE MUSCULAR DYSTROPHY NHS ENGLAND
FORIGERIMOD ACETATE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NHS ENGLAND
FOSAMPRENAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
FOSDENOPTERIN (CYCLIC PYRANOPTERIN MONOPHOSPHATE) MOLYBDENUM COFACTOR DEFICIENCY NHS ENGLAND
FOSLEVODOPA-FOSCARBIDOPA PARKINSON'S DISEASE NHS ENGLAND
Fostamatinib (Tavlesse®) Chronic immune thrombocytopenia ICB
FOSTEMSAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
Fremanezumab (Ajovy®) Migraine ICB
FUTIBATINIB CANCER
Cholangiocarcinoma
NHS ENGLAND
Galcanezumab (Emgality®) Migraine ICB
GALSULFASE MUCOPOLYSACCHARIDOSIS NHS ENGLAND
GANAXOLONE SEIIZURES ASSOCIATED WITH CYCLIN-DEPENDENT KINASE-LIKE 5 DEFICIENCY DISORDER NHS ENGLAND
GEFITINIB CANCER
Lung cancer
NHS ENGLAND
GEFITINIB CANCER
Lung cancer
NHS ENGLAND
GEMCITABINE CANCER
Biliary tract cancer
NHS ENGLAND
GEMCITABINE (WITH CAPECITABINE) CANCER
Pancreatic cancer
NHS ENGLAND
GEMTUZUMAB OZOGAMICIN  CANCER
AML
NHS ENGLAND
GILTERITINIB CANCER
AML
NHS ENGLAND
GIROCTOCOGENE FITELPARVOVEC HAEMOPHILIA A NHS ENGLAND
GIVOSIRAN HEPATIC PORPHYRIA NHS ENGLAND
GLATIRAMER MULTIPLE SCLEROSIS NHS ENGLAND
GLATIRAMER MULTIPLE SCLEROSIS NHS ENGLAND
GLECAPREVIR HEPATITIS C NHS ENGLAND
GLOFITAMAB CANCER
DLBCL
NHS ENGLAND
GLUCARPIDASE METHOTREXATE INDUCED RENAL DYSFUNCTION NHS ENGLAND
GLYCEROL PHENYLBUTYRATE UREA CYCLE DISORDERS NHS ENGLAND
Golimumab (Simponi®) Ankylosing Spondylitis ICB
Golimumab (Simponi®) Psoriatic arthritis ICB
Golimumab (Simponi®) Rheumatoid arthritis ICB
Golimumab (Simponi®) Ulcerative Colitis (moderate to severe) ICB
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ANTIBODY-POSITIVE PULMONARY ALVEOLAR PROTEINOSIS NHS ENGLAND
GRAZOPREVIR HEPATITIS C NHS ENGLAND
Guselkumab (Tremfya ®) Psoriatic arthritis ICB
Guselkumab (Tremfya ®) Moderate to severe plaque psoriasis ICB
HAEM ARGINATE HEPATIC PORPHYRIA NHS ENGLAND
HIGH PURITY FACTOR IX
(FACTOR IX - plasma derived)
HAEMOPHILIA B NHS ENGLAND
HIGH PURITY FACTOR VIII
(FACTOR VIII - plasma derived)
HAEMOPHILIA A NHS ENGLAND
HUMAN ALPHA1-PROTEINASE INHIBITOR EMPHYSEMA NHS ENGLAND
HUMAN COAGULATION FACTOR X FACTOR X DEFICIENCY NHS ENGLAND
HUMAN HETEROLOGOUS LIVER CELLS UREA CYCLE DISORDERS NHS ENGLAND
HUMAN NORMAL IMMUNOGLOBULINS - INTRAVENOUS  MULTIPLE INDICATIONS NHS ENGLAND
HUMAN NORMAL IMMUNOGLOBULINS - INTRAVENOUS  SCLEROMYXEDEMA NHS ENGLAND
HUMAN NORMAL IMMUNOGLOBULINS - SUBCUTANEOUS MULTIPLE INDICATIONS NHS ENGLAND
HUMAN NORMAL IMMUNOGLOBULINS - SUBCUTANEOUS SCLEROMYXEDEMA NHS ENGLAND
HUMAN PARATHYROID HORMONE-RELATED PROTEIN ANALOGUE MALE AND JUVENILE OSTEOPOROSIS
HYPOPARATHYROIDISM
NHS ENGLAND
HYDROXYPROPYL BETADEX   NHS ENGLAND
IBALIZUMAB HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
IBRUTINIB CANCER
CLL
NHS ENGLAND
IBRUTINIB CANCER
CLL
NHS ENGLAND
IBRUTINIB CANCER
CLL
NHS ENGLAND
IBRUTINIB CANCER
CLL
NHS ENGLAND
IBRUTINIB CANCER
CLL
NHS ENGLAND
IBRUTINIB CANCER
CLL
NHS ENGLAND
IBRUTINIB CANCER
MCL
NHS ENGLAND
IBRUTINIB CANCER
Waldenstrom's macroglobulinaemia
NHS ENGLAND
IBRUTINIB CANCER
Waldenstrom's macroglobulinaemia
NHS ENGLAND
ICATIBANT HEREDITARY ANGIOEDEMA - ACUTE TREATMENT ONLY NHS ENGLAND
ICATIBANT HEREDITARY ANGIOEDEMA - ACUTE TREATMENT ONLY NHS ENGLAND
IDEBENONE DUCHENNE MUSCULAR DYSTROPHY NHS ENGLAND
IDEBENONE LEBER HEREDITARY OPTIC NEUROPATHY  NHS ENGLAND
IDECABTAGENE VICLEUCEL CANCER
MM
NHS ENGLAND
IDELALISIB CANCER
CLL
NHS ENGLAND
IDURSULFASE MUCOPOLYSACCHARIDOSIS NHS ENGLAND
ILOPROST DIGITAL ULCERS NHS ENGLAND
ILOPROST PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
IMATINIB CANCER
CML
NHS ENGLAND
IMATINIB CANCER
CML
NHS ENGLAND
IMATINIB CANCER
CML
NHS ENGLAND
IMATINIB CANCER
Gastrointestinal stromal tumour
NHS ENGLAND
IMATINIB CANCER
Gastrointestinal stromal tumour
NHS ENGLAND
IMATINIB CANCER
Gastrointestinal stromal tumour
NHS ENGLAND
IMATINIB CHRONIC GRAFT VERSUS HOST DISEASE NHS ENGLAND
IMETELSTAT CANCER NHS ENGLAND
IMIGLUCERASE GAUCHER'S DISEASE NHS ENGLAND
IMLIFIDASE TRANSPLANT REJECTION PREVENTION IN HLA-SENSITISED PATIENTS NHS ENGLAND
INCLISIRAN PRIMARY HYPERCHOLESTEROLAEMIA OR MIXED DYSLIPIDAEMIA NHS ENGLAND
INCLISIRAN PRIMARY HYPERCHOLESTEROLAEMIA OR MIXED DYSLIPIDAEMIA NHS ENGLAND
INDINAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
INEBILIZUMAB MULTIPLE SCLEROSIS NHS ENGLAND
INFLIXIMAB BEHCETS SYNDROME NHS ENGLAND
INFLIXIMAB CONNECTIVE TISSUE DISEASE - INTERSTITAL LUNG DISEASE NHS ENGLAND
INFLIXIMAB CROHN'S DISEASE - PAEDIATRICS NHS ENGLAND
INFLIXIMAB GRAFT VERSUS HOST DISEASE NHS ENGLAND
INFLIXIMAB HIDRADENITIS SUPPURATIVA NHS ENGLAND
INFLIXIMAB JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
INFLIXIMAB PULMONARY SARCOIDOSIS NHS ENGLAND
INFLIXIMAB REFRACTORY SARCOIDOSIS NHS ENGLAND
INFLIXIMAB REFRACTORY OR PROGRESSIVE NEUROSARCOIDOSIS NHS ENGLAND
INFLIXIMAB ULCERATIVE COLITIS - PAEDIATRICS NHS ENGLAND
INFLIXIMAB UVEITIS  NHS ENGLAND
Infliximab (Inflectra, Remsima, Remicade®) Ankylosing spondylitis ICB
Infliximab (Inflectra, Remsima, Remicade®) Crohn’s disease ICB
Infliximab (Inflectra, Remsima, Remicade®) Psoriasis ICB
Infliximab (Inflectra, Remsima, Remicade®) Psoriatic Arthritis ICB
Infliximab (Inflectra, Remsima, Remicade®) Rheumatoid arthritis ICB
Infliximab (Inflectra, Remsima, Remicade®) Diarrhoea and colitis relating to ICPI therapy ICB
Infliximab (Inflectra, Remsima, Remicade®) Ulcerative Colitis (moderate to severe) ICB
INOTERSEN AMYLOIDOSIS NHS ENGLAND
INOTUZUMAB OZOGAMICIN  CANCER
ALL
NHS ENGLAND
INTERFERON ALFA (Pegylated and non-pegylated) HEPATITIS B AND C NHS ENGLAND
INTERFERON ALFA N3 MIDDLE EAST RESPIRATORY SYNDROME NHS ENGLAND
INTERFERON BETA MULTIPLE SCLEROSIS NHS ENGLAND
INTERFERON BETA MULTIPLE SCLEROSIS NHS ENGLAND
INTERFERON BETA MULTIPLE SCLEROSIS NHS ENGLAND
INVERTASE   NHS ENGLAND
INVIMESTROCEL STROKE NHS ENGLAND
IPILIMUMAB CANCER
Lung cancer
NHS ENGLAND
IPILIMUMAB CANCER
Melanoma
NHS ENGLAND
IPILIMUMAB CANCER
Melanoma
NHS ENGLAND
IPILIMUMAB CANCER
Melanoma
NHS ENGLAND
IPILIMUMAB CANCER
Mesothelioma
NHS ENGLAND
IPILIMUMAB CANCER
Renal cell carcinoma
NHS ENGLAND
IPILIMUMAB  CANCER
Colorectal cancer
NHS ENGLAND
IPTACOPAN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA NHS ENGLAND
ISATUXIMAB CANCER
MM
CDF
ISATUXIMAB CANCER
MM
CDF
ISAVUCONAZOLE FUNGAL INFECTION (LICENSED INDICATIONS) NHS ENGLAND
IVACAFTOR CYSTIC FIBROSIS NHS ENGLAND
IVOSIDENIB CANCER
Cholangiocarcinoma
NHS ENGLAND
IVOSIDENIB CANCER
AML
NHS ENGLAND
IXAZOMIB AMYLOIDOSIS NHS ENGLAND
IXAZOMIB CANCER
MM
NHS ENGLAND
Ixekizumab (Taltz®) Moderate to severe plaque psoriasis ICB
Ixekizumab (Taltz®) Axial spondyloarthritis ICB
Ixekizumab (Taltz®) Psoriatic Arthritis ICB
LANADELUMAB HEREDITARY ANGIOEDEMA - PROPHYLACTIC TREATMENT NHS ENGLAND
LANREOTIDE ACROMEGALY NHS ENGLAND
LANREOTIDE CANCER NHS ENGLAND
LANREOTIDE CONGENITAL HYPERINSULINISM NHS ENGLAND
LAPATINIB CANCER
Breast cancer
NHS ENGLAND
L-ARGININE UREA CYCLE DISORDERS NHS ENGLAND
LARONIDASE MUCOPOLYSACCHARIDOSIS NHS ENGLAND
LAROTRECTINIB CANCER
NTRK fusion positive solid tumours
CDF
LEBRIKIZUMAB ASTHMA NHS ENGLAND
LEBRIKIZUMAB MODERATE TO SEVERE ATOPIC DERMATITIS - PAEDIATRICS NHS ENGLAND
Lebrikizumab (Ebglyss®) Moderate to severe atopic dermatitis ICB
LENABASUM (ANABASUM) SCLERODERMA NHS ENGLAND
LENACAPAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
LENADOGENE NOLPARVOVEC LEBER HEREDITARY OPTIC NEUROPATHY  NHS ENGLAND
LENALIDOMIDE CANCER
Follicular lymphoma
NHS ENGLAND 
LENALIDOMIDE CANCER
MDS
NHS ENGLAND 
LENALIDOMIDE CANCER
MM
NHS ENGLAND 
LENALIDOMIDE CANCER
MM
NHS ENGLAND 
LENALIDOMIDE CANCER
MM
NHS ENGLAND 
LENALIDOMIDE CANCER
MM
NHS ENGLAND 
LENALIDOMIDE CANCER
MM
NHS ENGLAND 
LENALIDOMIDE CANCER
MM
NHS ENGLAND 
LENALIDOMIDE CANCER
MM
CDF
LENALIDOMIDE POEMS NHS ENGLAND
LENIOLISIB PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME NHS ENGLAND
LENVATINIB CANCER
Endometrial cancer
NHS ENGLAND
LENVATINIB CANCER
Hepatocellular carcinoma
NHS ENGLAND 
LENVATINIB CANCER
Renal cell carcinoma
NHS ENGLAND 
LENVATINIB CANCER
Renal cell carcinoma
NHS ENGLAND
LENVATINIB CANCER
Thyroid cancer
NHS ENGLAND 
LERIGLITAZONE ADRENOMYELONEUROPTHY (AMN) IN MALE ADULTS NHS ENGLAND
LERONLIMAB HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
LETERMOVIR CYTOMEGALOVIRUS NHS ENGLAND
LETETRESGENE AUTOLEUCEL CANCER
Sarcoma
NHS ENGLAND
LEVODOPA + CARBIDOPA + ENTACAPONE (INTESTINAL GEL) PARKINSON'S DISEASE NHS ENGLAND
LEVODOPA + CARBIDOPA INTESTINAL GEL PARKINSON'S DISEASE NHS ENGLAND
LEVOFLOXACIN (INHALED) CYSTIC FIBROSIS NHS ENGLAND
LEVOKETOCONAZOLE CUSHING'S DISEASE NHS ENGLAND
LIFILEUCEL CANCER NHS ENGLAND
Liothyronine Myxoedema coma ICB
LIPOSOMAL CYTARABINE-DAUNORUBICIN  CANCER
AML
NHS ENGLAND
LISOCABTAGENE MARALEUCEL CANCER
NHL
NHS ENGLAND
LOMITAPIDE HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA NHS ENGLAND
LONAFARNIB PROGERIA AND PROGEROID LAMINOPATHIES NHS ENGLAND
LONCASTUXIMAB CANCER
B-cell lymphoma
NHS ENGLAND
LONOCTOCOG ALFA
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
LOPINAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
LORLATINIB CANCER
Lung cancer
NHS ENGLAND
LORLATINIB CANCER
Lung cancer
NHS ENGLAND
LUMACAFTOR + IVACAFTOR CYSTIC FIBROSIS NHS ENGLAND
LUMACAFTOR + IVACAFTOR CYSTIC FIBROSIS NHS ENGLAND
LUMASIRAN PRIMARY HYPEROXALURIA NHS ENGLAND
LUSPATERCEPT CANCER NHS ENGLAND
Lusutrombopag (Mulpleo ®) Thrombocytopenia in people with chronic liver disease ICB
LUTETIUM (177Lu) OXODOTREOTIDE  CANCER
NET
NHS ENGLAND
LUTETIUM (177Lu) VIPIVOTIDE TETRAXETAN CANCER
Prostate cancer
NHS ENGLAND
MACITENTAN PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
MANNITOL (INHALED) CYSTIC FIBROSIS NHS ENGLAND
MANNITOL (INHALED) CYSTIC FIBROSIS NHS ENGLAND
MARALIXIBAT ALAGILLE SYNDROME NHS ENGLAND
MARAVIROC HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
MARAVIROC NATALIZUMAB INDUCED PML NHS ENGLAND
MARIBAVIR CYTOMEGALOVIRUS NHS ENGLAND
MARNETEGRAGENE AUTOTEMCEL LEUKOCYTE ADHESION DEFICIENCY-1 NHS ENGLAND
MARSTACIMAB HAEMOPHILIA A AND B NHS ENGLAND
MASITINIB CANCER NHS ENGLAND
MAVACAMTEN SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY NHS ENGLAND
MECASERMIN GROWTH FAILURE NHS ENGLAND
MEPOLIZUMAB ASTHMA, EOSINOPHILIC ASTHMA NHS ENGLAND
MERCAPTAMINE HCL VISCOUS EYEDROPS CORNEAL CYSTINE DEPOSITS NHS ENGLAND
MESENCHYMAL STEM CELLS  ACUTE GVHD AND OTHER INDICATIONS (BCSH) NHS ENGLAND
METRELEPTIN  CONGENITAL LEPTIN DEFICIENCY NHS ENGLAND
METRELEPTIN  DYSLIPIDAEMIA NHS ENGLAND
METRELEPTIN  LIPODYSTROPHY NHS ENGLAND
MEXILETINE NON-DYSTROPHIC MYOTONIC DISORDERS NHS ENGLAND
MICAFUNGIN FUNGAL INFECTION NHS ENGLAND
MIDOSTAURIN CANCER
AML
NHS ENGLAND
MIDOSTAURIN CANCER
Mastocytosis
NHS ENGLAND
MIFAMURTIDE CANCER
Osteosarcoma
NHS ENGLAND
MIGALASTAT FABRY'S DISEASE NHS ENGLAND
MIGLUSTAT GLYCOGEN STORAGE DISEASE TYPE II (POMPE DISEASE) NHS ENGLAND
MIGLUSTAT GAUCHER'S DISEASE/ NIEMANN-PICK NHS ENGLAND
Mirikizumab (Omvoh®) Ulcerative Colitis (moderate to severe) ICB
MITAPIVAT PYRUVATE KINASE DEFICIENCY NHS ENGLAND
MOBOCERTINIB CANCER
Lung cancer
NHS ENGLAND
MOGAMULIZUMAB MYCOSIS FUNGOIDES NHS ENGLAND
MOMELOTINIB CANCER
Myelofibrosis-related splenomegaly or symptoms
NHS ENGLAND
MOROCTOCOG ALFA
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
MOSUNETUZUMAB CANCER
Follicular lymphoma
NHS ENGLAND
MOZAFANCOGENE AUTOTEMCEL FANCONI ANAEMA NHS ENGLAND
MYCOPHENOLATE MOFETIL KIDNEY TRANSPLANT - ADULTS NHS ENGLAND
MYCOPHENOLATE MOFETIL KIDNEY TRANSPLANT - CHILDREN & YOUNG PEOPLE NHS ENGLAND
MYCOPHENOLATE MOFETIL TRANSPLANT IMMUNOSUPPRESSION ONLY  - ADULTS NHS ENGLAND
MYCOPHENOLATE MOFETIL TRANSPLANT IMMUNOSUPPRESSION ONLY  - CHILDREN & YOUNG PEOPLE NHS ENGLAND
MYCOPHENOLIC ACID (sodium salt) KIDNEY TRANSPLANT - ADULTS NHS ENGLAND
MYCOPHENOLIC ACID (sodium salt) KIDNEY TRANSPLANT - CHILDREN & YOUNG PEOPLE NHS ENGLAND
MYCOPHENOLIC ACID (sodium salt) TRANSPLANT IMMUNOSUPPRESSION ONLY  - ADULTS NHS ENGLAND
MYCOPHENOLIC ACID (sodium salt) TRANSPLANT IMMUNOSUPPRESSION ONLY  - CHILDREN & YOUNG PEOPLE NHS ENGLAND
NAB-PACLITAXEL - ALBUMIN BOUND PACLITAXEL (WITH ATEZOLIZUMAB) CANCER
Breast cancer
NHS ENGLAND
NAB-PACLITAXEL - ALBUMIN BOUND PACLITAXEL (WITH GEMCITABINE) CANCER
Pancreatic cancer
NHS ENGLAND
NADOFARANGENE FIRADENOVEC CANCER
Bladder
NHS ENGLAND
NARSOPLIMAB HAEMATOPOIETIC STEM CELL TRANSPLANT-RELATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA) NHS ENGLAND
NATALIZUMAB MULTIPLE SCLEROSIS NHS ENGLAND
NATALIZUMAB MULTIPLE SCLEROSIS NHS ENGLAND
NAVITOCLAX MYELOFIBROSIS NHS ENGLAND
NECITUMUMAB CANCER
Lung cancer
NHS ENGLAND
NEDOSIRAN HYPEROXALURIA NHS ENGLAND
NELARABINE CANCER
ALL/NHL
NHS ENGLAND
CDF
NELFINAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
NERATINIB CANCER
Breast cancer
NHS ENGLAND
NEVIRAPINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
NEXOBRID (BROMELAIN)   NHS ENGLAND
NICARDIPINE - INTRACRANIAL IMPLANT SUBARACHNOID HAEMORRHAGE NHS ENGLAND
NILOTINIB CANCER
CML
NHS ENGLAND
NILOTINIB CANCER
CML
NHS ENGLAND
NINTEDANIB CANCER
Lung cancer
NHS ENGLAND
NINTEDANIB IDIOPATHIC PULMONARY FIBROSIS NHS ENGLAND
NINTEDANIB IDIOPATHIC PULMONARY FIBROSIS NHS ENGLAND
NINTEDANIB PROGESSIVE FIBROSING INTERSTITIAL LUNG DISEASES  NHS ENGLAND
NIRAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
NHS ENGLAND
NIRAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
CDF
Nirmatrelvir plus ritonavir (Paxlovid®) Covid-19 ICB
NIRSEVIMAB RSV PROPHYLAXIS NHS ENGLAND
NITAZOXANIDE HEPATITIS C NHS ENGLAND
NITISINONE ALKAPTONURIA NHS ENGLAND
NITISINONE TYROSINAEMIA NHS ENGLAND
NITRIC OXIDE PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
NIVOLUMAB  CANCER
Colorectal cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Gastric, gastro-oesophageal or oesophageal carcinoma
NHS ENGLAND
NIVOLUMAB  CANCER
Head and neck cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Hodgkin lymphoma
NHS ENGLAND
NIVOLUMAB  CANCER
Lung cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Lung cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Lung cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Lung cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Melanoma
NHS ENGLAND
NIVOLUMAB  CANCER
Melanoma
NHS ENGLAND
NIVOLUMAB  CANCER
Melanoma
NHS ENGLAND
NIVOLUMAB  CANCER
Melanoma
NHS ENGLAND
NIVOLUMAB  CANCER
Mesothelioma
NHS ENGLAND
NIVOLUMAB  CANCER
Oesophageal cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Oesophageal carcinoma
NHS ENGLAND
NIVOLUMAB  CANCER
Oesophageal carcinoma
NHS ENGLAND
NIVOLUMAB  CANCER
Renal cell carcinoma
NHS ENGLAND
NIVOLUMAB  CANCER
Renal cell carcinoma
NHS ENGLAND
NIVOLUMAB  CANCER
Renal cell carcinoma
NHS ENGLAND
NIVOLUMAB  CANCER
Urothelial cancer
NHS ENGLAND
NIVOLUMAB  CANCER
Urothelial carcinoma
NHS ENGLAND
NONACOG ALFA
(FACTOR IX - recombinant) 
HAEMOPHILIA B NHS ENGLAND
NONACOG BETA PEGOL
(FACTOR IX - recombinant) 
HAEMOPHILIA B NHS ENGLAND
NONACOG GAMMA
(FACTOR IX - recombinant) 
HAEMOPHILIA B NHS ENGLAND
NUSINERSEN SPINAL MUSCULAR ATROPHY NHS ENGLAND
OBECABTAGENE AUTOLEUCEL CANCER
ALL
NHS ENGLAND
OBETICHOLIC ACID PRIMARY BILIARY CHOLANGITIS NHS ENGLAND
OBILTOXAXIMAB ANTHRAX NHS ENGLAND
OBINUTUZUMAB CANCER
DLBCL
NHS ENGLAND
OBINUTUZUMAB CANCER
CLL
NHS ENGLAND
OBINUTUZUMAB CANCER
CLL
NHS ENGLAND
OBINUTUZUMAB CANCER
Follicular lymphoma
NHS ENGLAND
OBINUTUZUMAB CANCER
Follicular lymphoma
NHS ENGLAND
OBINUTUZUMAB THROMBOTIC THROMBOCYTOPENIC PURPURA  NHS ENGLAND
OBINUTUZUMAB SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NHS ENGLAND
OCRELIZUMAB MULTIPLE SCLEROSIS NHS ENGLAND
OCRELIZUMAB MULTIPLE SCLEROSIS NHS ENGLAND
Ocriplasmin (Jetrea®) Retinal disorders- Vitreomacular traction ICB
OCTOCOG ALFA
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
OCTREOLIN ACROMEGALY NHS ENGLAND
OCTREOTIDE ACROMEGALY NHS ENGLAND
OCTREOTIDE CANCER NHS ENGLAND
OCTREOTIDE CONGENITAL HYPERINSULINISM NHS ENGLAND
ODEVIXIBAT PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS NHS ENGLAND
OFATUMUMAB MULTIPLE SCLEROSIS NHS ENGLAND
OLAPARIB CANCER
Breast cancer
NHS ENGLAND
OLAPARIB CANCER
Prostate cancer
NHS ENGLAND
OLAPARIB CANCER
Prostate cancer
NHS ENGLAND
OLAPARIB CANCER
Breast cancer
NHS ENGLAND
OLAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
NHS ENGLAND
OLAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
NHS ENGLAND
OLAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
NHS ENGLAND
OLAPARIB CANCER
Pancreatic cancer
NHS ENGLAND
OLAPARIB CANCER
Prostate cancer
NHS ENGLAND
OLENASUFLIGENE RELDUPARVOVEC MUCOPOLYSACCHARIDOSIS NHS ENGLAND
OLIPUDASE ALFA ACID SPHINGOMYELINASE DEFICIENCY  NHS ENGLAND
OMALIZUMAB ASTHMA NHS ENGLAND
Omalizumab (Xolair®) Severe Chronic Spontaneous Urticaria ICB
OMBITASVIR + PARITAPREVIR+ RITONAVIR + DASABUVIR + RIBAVIRIN HEPATITIS C NHS ENGLAND
ONASEMNOGENE ABEPARVOVEC SPINAL MUSCULAR ATROPHY NHS ENGLAND
ONASEMNOGENE ABEPARVOVEC SPINAL MUSCULAR ATROPHY NHS ENGLAND
OSILODROSTAT CUSHING'S DISEASE NHS ENGLAND
OSIMERTINIB CANCER
Lung cancer
NHS ENGLAND
OSIMERTINIB CANCER
Lung cancer
NHS ENGLAND
OSIMERTINIB CANCER
Lung cancer
CDF
OSTEOCHONDRAL ALLOGRAFT OSTEOCHONDRAL LESIONS KNEE NHS ENGLAND
OZANIMOD MULTIPLE SCLEROSIS NHS ENGLAND
Ozanimod (Zeposia®) Moderately to severe ulceratve colitis ICB
PACRITINIB MYELOFIBROSIS NHS ENGLAND
PALBOCICLIB CANCER
Breast cancer
NHS ENGLAND
PALBOCICLIB CANCER
Breast cancer
NHS ENGLAND
PALIVIZUMAB RSV PROPHYLAXIS NHS ENGLAND
PALOPEGTERIPARATIDE HYPOPARATHYROIDISM  NHS ENGLAND
PALOVAROTENE FYBRODYSPLASIA OSSIFICANS PROGRESSIVA NHS ENGLAND
PANITUMUMAB CANCER
Colorectal cancer
NHS ENGLAND
PANITUMUMAB CANCER
Colorectal cancer
NHS ENGLAND
PANOBINOSTAT CANCER
MM
NHS ENGLAND
PARA-AMINOSALICYLIC ACID MULTI DRUG RESISTANT TB NHS ENGLAND
PARATHYROID HORMONE SPECIALIST ENDOCRINOLOGY CONDITIONS NHS ENGLAND
Parathyroid Hormone (Preotact®) Osteoporosis ICB
PARENTERAL NUTRITION (HOME USE) INTESTINAL FAILURE  NHS ENGLAND
PARENTERAL NUTRITION (HOME USE) INTESTINAL FAILURE  NHS ENGLAND
PARENTERAL NUTRITION (INPATIENT USE) INTESTINAL FAILURE; INADEQUATE/ UNSAFE ENTERAL FEEDING NHS ENGLAND
PARENTERAL NUTRITION (INPATIENT USE) INTESTINAL FAILURE; INADEQUATE/ UNSAFE ENTERAL FEEDING NHS ENGLAND
PARENTERAL NUTRITION (INPATIENT USE) INTESTINAL FAILURE; INADEQUATE/ UNSAFE ENTERAL FEEDING NHS ENGLAND
PARICALCITOL HYPERPARATHYROIDISM  NHS ENGLAND
PARICALCITOL HYPERPARATHYROIDISM  NHS ENGLAND
PARITAPREVIR  HEPATITIS C NHS ENGLAND
PASIREOTIDE ACROMEGALY NHS ENGLAND
PASIREOTIDE DIASPARTATE CUSHING'S DISEASE NHS ENGLAND
PATISIRAN AMYLOIDOSIS NHS ENGLAND
PAZOPANIB CANCER
Granular cell tumour
NHS ENGLAND
PAZOPANIB CANCER
Renal cell carcinoma
NHS ENGLAND
PEGASPARGASE CANCER
ALL
NHS ENGLAND
PEGBELFERMIN ALCOHOLIC FATTY LIVER DISEASE NHS ENGLAND
PEGCETACOPLAN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA NHS ENGLAND
PEGINTERFERON ALFA-2A HEPATITIS B NHS ENGLAND
PEGINTERFERON ALFA-2A HEPATITIS B NHS ENGLAND
PEGINTERFERON ALFA-2A HEPATITIS C NHS ENGLAND
PEGINTERFERON ALFA-2A HEPATITIS C NHS ENGLAND
PEGINTERFERON ALFA-2A HEPATITIS C NHS ENGLAND
PEGINTERFERON ALFA-2A HEPATITIS C NHS ENGLAND
PEGINTERFERON ALFA-2A HEPATITIS C NHS ENGLAND
PEGINTERFERON ALFA-2A MYELOPROLIFERATIVE NEOPLASMS NHS ENGLAND
PEGINTERFERON BETA-1A MULTIPLE SCLEROSIS NHS ENGLAND
PEGINTERFERON BETA-1A MULTIPLE SCLEROSIS NHS ENGLAND
PEGUNIGALSIDASE ALFA FABRY'S DISEASE NHS ENGLAND
PEGVALIASE PHENYLKETONURIA NHS ENGLAND
PEGVISOMANT ACROMEGALY NHS ENGLAND
PEGYLATED LIPOSOMAL DOXORUBICIN CANCER
Ovarian cancer
NHS ENGLAND
PEGYLATED LIPOSOMAL DOXORUBICIN CANCER
Sarcoma / Kaposi Sarcoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Endometrial, biliary, colorectal, gastric or small intestine cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Breast cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Breast cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Colorectal cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Endometrial cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Head and neck cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Hodgkin lymphoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Hodgkin lymphoma
CDF
PEMBROLIZUMAB CANCER
Hodgkin lymphoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Lung cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Lung cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Lung cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Lung cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Lung cancer
CDF
PEMBROLIZUMAB CANCER
Lung cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Lung cancer
CDF
PEMBROLIZUMAB CANCER
Melanoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Melanoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Melanoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Melanoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Gastric/ gastro-oesophageal junction cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Oesophageal/gastro-oesophageal junction cancer
NHS ENGLAND
PEMBROLIZUMAB CANCER
Renal cell carcinoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Renal cell carcinoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Renal cell carcinoma
NHS ENGLAND
PEMBROLIZUMAB CANCER
Urothelial carcinoma
NHS ENGLAND
PEMBROLIZUMAB DRUG RESISTANT GESTATIONAL TROPHOBLASTIC NEOPLASIA NHS ENGLAND
PEMBROLIZUMAB CANCER
Cervical cancer
NHS ENGLAND
PEMETREXED CANCER
Lung cancer
NHS ENGLAND
PEMETREXED CANCER
Lung cancer
NHS ENGLAND
PEMETREXED CANCER
Lung cancer
NHS ENGLAND
PEMETREXED CANCER
Lung cancer
NHS ENGLAND
PEMETREXED CANCER
Lung cancer
NHS ENGLAND
PEMETREXED CANCER
Mesothelioma
NHS ENGLAND
PEMIGATINIB CANCER
Cholangiocarcinoma
NHS ENGLAND
PEPTIDE RECEPTOR RADIONUCLEOTIDE THERAPY CANCER CDF
PERTUZUMAB CANCER
Breast cancer
NHS ENGLAND
PERTUZUMAB CANCER
Breast cancer
NHS ENGLAND
PERTUZUMAB CANCER
Breast cancer
NHS ENGLAND
PIBRENTASVIR HEPATITIS C NHS ENGLAND
PIRFENIDONE IDIOPATHIC PULMONARY FIBROSIS NHS ENGLAND
PIXANTRONE CANCER
NHL
NHS ENGLAND
PLATELET LYSATE THERAPY   NHS ENGLAND
PLERIXAFOR STEM CELL MOBILISATION NHS ENGLAND
PLERIXAFOR STEM CELL MOBILISATION NHS ENGLAND
POLATUZUMAB VEDOTIN CANCER
B-cell lymphoma
NHS ENGLAND
POLATUZUMAB VEDOTIN CANCER
B-cell lymphoma
NHS ENGLAND
POMALIDOMIDE CANCER
MM
NHS ENGLAND
POMALIDOMIDE CANCER
MM
NHS ENGLAND
POMALIDOMIDE CANCER
MM
NHS ENGLAND
POMALIDOMIDE MYELOFIBROSIS NHS ENGLAND
PONATINIB CANCER
ALL
NHS ENGLAND
PONESIMOD MULTIPLE SCLEROSIS NHS ENGLAND
POSACONAZOLE FUNGAL INFECTION NHS ENGLAND
PRALSETINIB CANCER
Lung cancer
NHS ENGLAND
PRETOMANID TB NHS ENGLAND
PROTEIN C HUMAN (acute use) FOR SPECIALISED INDICATIONS NHS ENGLAND
PROTEIN C HUMAN (long-term use) FOR SPECIALISED INDICATIONS NHS ENGLAND
PROTEIN KINASE INHIBITORS ENDOCRINOLOGY; NON-MALIGNANT CONDITIONS NHS ENGLAND
PROTHROMBIN COMPLEX CONCENTRATE (PCC) AS PER BCSH GUIDELINES FOR SPECIALISED INDICATIONS NHS ENGLAND
QUIZARTINIB CANCER
AML
CDF
QUIZARTINIB CANCER
AML
NHS ENGLAND
RADIUM-223 DICHLORIDE CANCER
Prostate cancer
NHS ENGLAND
RALTEGRAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
RAMUCIRUMAB CANCER
Gastric or gastro-oesophageal adenocarcinoma
NHS ENGLAND
RAMUCIRUMAB CANCER
Lung cancer
NHS ENGLAND
RANIBIZUMAB RETINOPATHY OF PREMATURITY NHS ENGLAND
Ranibizumab (Lucentis®/ Ongavia®) Macular oedema (Retinal vein occlusion) ICB
Ranibizumab (Lucentis®/ Ongavia®) Diabetic Macular Oedema ICB
Ranibizumab (Lucentis®/ Ongavia®) Macular degeneration(wet age-related) ICB
Ranibizumab (Lucentis®/ Ongavia®) Choroidal neovascularisation (CNV) associated with pathological myopia ICB
RASBURICASE HYPERURICAEMIA NHS ENGLAND
RAVULIZUMAB AHUS NHS ENGLAND
RAVULIZUMAB PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA NHS ENGLAND
REGORAFENIB CANCER
Colorectal cancer
NHS ENGLAND
REGORAFENIB CANCER
Gastrointestinal stromal tumour
NHS ENGLAND
REGORAFENIB CANCER
Hepatocellular carcinoma
NHS ENGLAND
RELATLIMAB CANCER
Melanoma
NHS ENGLAND
Remdesivir (Veklury®) Covid-19 ICB
REPARIXIN PREVENTION OF DELAYED GRAFT FUNCTION NHS ENGLAND
RESLIZUMAB ASTHMA NHS ENGLAND
REZAFUNGIN FUNGAL INFECTION NHS ENGLAND
RIBOCICLIB CANCER
Breast cancer
NHS ENGLAND
RIBOCICLIB CANCER
Breast cancer
NHS ENGLAND
RILPIVIRINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
RILPIVIRINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
RILPIVIRINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
Rimegepant (Vydura®) treating migraine ICB
Rimegepant (Vydura®) preventing Migraine ICB
RIOCIGUAT PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
RIOCIGUAT PULMONARY ARTERIAL HYPERTENSION (CTEPH) NHS ENGLAND
RIPRETINIB CANCER
Gastrointestinal stromal tumour
NHS ENGLAND
RISANKIZUMAB CROHN'S DISEASE (ADOLESCENTS 16 - 17 YEARS) NHS ENGLAND
Risankizumab (Skyrizi®) Ulcerative colitis ICB
Risankizumab (Skyrizi®) Psoriatic Arthritis ICB
Risankizumab (Skyrizi®) Crohn's disease ICB
Risankizumab (Skyrizi®) Moderate to severe plaque psoriasis ICB
RISDIPLAM SPINAL MUSCULAR ATROPHY NHS ENGLAND
Ritlecitinib (Litfulo®) Severe Alopecia areata ICB
RITONAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
RITUXIMAB ABO-INCOMPATIBLE KIDNEY TRANSPLANTS NHS ENGLAND
RITUXIMAB ACQUIRED HAEMOPHILIA NHS ENGLAND
RITUXIMAB ANCA-ASSOCIATED VASCULITIS NHS ENGLAND
RITUXIMAB ANCA-ASSOCIATED VASCULITIS NHS ENGLAND
RITUXIMAB BEHCETS SYNDROME NHS ENGLAND
RITUXIMAB ANTI-NMDAR AUTOIMMUNE ENCEPHALITIS NHS ENGLAND
RITUXIMAB CASTLEMAN'S DISEASE NHS ENGLAND
RITUXIMAB CHRONIC GRAFT VERSUS HOST DISEASE NHS ENGLAND
RITUXIMAB CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY NHS ENGLAND
RITUXIMAB CONNECTIVE TISSUE DISEASE - INTERSTITIAL LUNG DISEASE NHS ENGLAND
RITUXIMAB CYTOPENIA COMPLICATING PRIMARY IMMUNODEFICIENCY NHS ENGLAND
RITUXIMAB DELAYED HAEMOLYTIC TRANSFUSION REACTIONS AND HYPERHAEMOLYSIS IN PATIENTS WITH HAEMOGLOBINOPATHIES NHS ENGLAND
RITUXIMAB DERMATOMYOSITIS AND POLYMYOSITIS (ADULTS) NHS ENGLAND
RITUXIMAB FOCAL SEGMENTAL GLOMERULOSCLEROSIS NHS ENGLAND
RITUXIMAB IDIOPATHIC MEMBRANOUS NEPHROPATHY NHS ENGLAND
RITUXIMAB IGM PARAPROTEINAEMIC DEMYELINATING PERIPHERAL NEUROPATHY NHS ENGLAND
RITUXIMAB IMMUNOBULLOUS DISEASE NHS ENGLAND
RITUXIMAB IMMUNOGLOBIN G4 RELATED DISEASE NHS ENGLAND
RITUXIMAB JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
RITUXIMAB MULTIFOCAL MOTOR NEUROPATHY NHS ENGLAND
RITUXIMAB MYASTHENIA GRAVIS NHS ENGLAND
RITUXIMAB NEUROMYELITIS OPTICA NHS ENGLAND
RITUXIMAB NODAL/PARANODAL ANTIBODY POSITIVE INFLAMMATORY AUTOIMMUNE NEUROPATHY NHS ENGLAND
RITUXIMAB PEMPHIGUS VULGARIS AND PEMPHIGOID DISEASE NHS ENGLAND
RITUXIMAB PRIMARY SJOGREN'S SYNDROME (PSS) NHS ENGLAND
RITUXIMAB STEROID RESISTANT NEPHROTIC SYNDROME - PAEDIATRICS NHS ENGLAND
RITUXIMAB STEROID SENSITIVE NEPHROTIC SYNDROME NHS ENGLAND
RITUXIMAB SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) NHS ENGLAND
RITUXIMAB THROMBOTIC THROMBOCYTOPENIC PURPURA  NHS ENGLAND
RITUXIMAB VASCULITIS OF THE PERIPHERAL NERVOUS SYSTEM NHS ENGLAND
Rituximab (Mabthera®, Truxima ®, Rixathon ®) Rheumatoid Arthritis ICB
Rituximab (Mabthera®, Truxima ®, Rixathon ®) Immune (idiopathic) thrombocytopenic purpura (ITP) ICB
RITUXIMAB IV CANCER NHS ENGLAND
RITUXIMAB IV CANCER
ALL
NHS ENGLAND
RITUXIMAB IV CANCER
B-cell lymphoma
NHS ENGLAND
RITUXIMAB IV CANCER
CLL
NHS ENGLAND
RITUXIMAB IV CANCER
CLL
NHS ENGLAND
RITUXIMAB IV CANCER
CLL
NHS ENGLAND
RITUXIMAB IV CANCER
Follicular lymphoma
NHS ENGLAND
RITUXIMAB IV CANCER
Follicular lymphoma
NHS ENGLAND
RITUXIMAB IV CANCER
NHL
NHS ENGLAND
RITUXIMAB IV CANCER
NHL
NHS ENGLAND
RITUXIMAB SUBCUTANEOUS FORMULATION CANCER
Follicular lymphoma
NHS ENGLAND
RIVIPANSEL SODIUM HEPATIC VENO-OCCLUSIVE DISEASE NHS ENGLAND
RIVIPANSEL SODIUM SICKLE CELL DISEASE NHS ENGLAND
Romiplostim (Nplate®) Thrombocytopenia purpura ICB
Romosozumab (Evenity®) Osteoporosis ICB
ROPEGINTERFERON ALFA-2b  HEPATITIS C NHS ENGLAND
ROPEGINTERFERON ALFA-2b  MYELOPROLIFERATIVE NEOPLASMS NHS ENGLAND
Roxadustat Symptomatic anaemia in chronic kidney disease ICB
RP-L102 FANCONI ANAEMA NHS ENGLAND
RP-L201 LEUKOCYTE ADHESION DEFICIENCY-1 (LAD-1) NHS ENGLAND
RUCAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
CDF
RUCAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
CDF
RUCAPARIB CANCER
Ovarian, fallopian tube and peritoneal cancer
NHS ENGLAND
RURIOCTOCOG ALFA PEGOL
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
RUXOLITINIB CANCER
Polycythaemia vera
NHS ENGLAND
RUXOLITINIB CANCER
Myelofibrosis
NHS ENGLAND
SACITUZUMAB GOVITECAN CANCER
Breast cancer
NHS ENGLAND
SAPROPTERIN ADULTS AND CHILDREN WITH PHENYLKETONURIA NHS ENGLAND
SAPROPTERIN ADULTS AND CHILDREN WITH PHENYLKETONURIA NHS ENGLAND
SAPROPTERIN ADULTS AND CHILDREN WITH PHENYLKETONURIA NHS ENGLAND
SAPROPTERIN ADULTS AND CHILDREN WITH TETRAHYDROBIOPTERIN DISORDERS NHS ENGLAND
SAQUINAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
Sarilumab (Kevzara®) Rheumatoid Arthritis ICB
SATRALIZUMAB NEUROMYELITIS OPTICA NHS ENGLAND
SEBELIPASE ALFA WOLMAN DISEASE NHS ENGLAND
SECUKINUMAB PLAQUE PSORIASIS - PAEDIATRICS NHS ENGLAND
SECUKINUMAB HIDRADENITIS SUPPURATIVA NHS ENGLAND
Secukinumab (Cosentyx®) Ankylosing spondylitis ICB
Secukinumab (Cosentyx®) Moderate to severe plaque psoriasis ICB
Secukinumab (Cosentyx®) Non-radiographic axial spondyloarthritis ICB
Secukinumab (Cosentyx®) Psoriatic Arthritis ICB
SELEXIPAG PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
SELINEXOR CANCER
MM
NHS ENGLAND
SELINEXOR CANCER
MM
NHS ENGLAND
SELPERCATINIB CANCER
Lung cancer
CDF
SELPERCATINIB CANCER
Lung cancer
CDF
SELPERCATINIB CANCER
Thyroid cancer
CDF
SELPERCATINIB CANCER
Thyroid cancer
CDF
SELPERCATINIB CANCER
Thyroid cancer
CDF
SELUMETINIB TYPE 1 (NF-1) IN CHILDREN WHO HAVE SYMPTOMATIC, INOPERABLE PLEXIFORM NEUROFIBROMAS (PN) NHS ENGLAND
SETMELANOTIDE LEPTIN DEFICIENCY NHS ENGLAND
SETMELANOTIDE BARDET-BIEDL SYNDROME NHS ENGLAND
SETRUSUMAB OSTEOGENESIS IMPERFECTA NHS ENGLAND
SILDENAFIL PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
SILDENAFIL PULMONARY ARTERIAL HYPERTENSION  NHS ENGLAND
SILTUXIMAB CASTLEMAN'S DISEASE NHS ENGLAND
SIMOCTOCOG ALFA
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
SIPONIMOD MULTIPLE SCLEROSIS NHS ENGLAND
SIROLIMUS LYMPHANGIOLEIOMYOMATOSIS NHS ENGLAND
SIROLIMUS KIDNEY TRANSPLANT - ADULTS NHS ENGLAND
SIROLIMUS KIDNEY TRANSPLANT - CHILDREN & YOUNG PEOPLE NHS ENGLAND
SIROLIMUS TRANSPLANT IMMUNOSUPPRESSION ONLY - ADULTS NHS ENGLAND
SIROLIMUS TRANSPLANT IMMUNOSUPPRESSION ONLY - CHILDREN & YOUNG PEOPLE NHS ENGLAND
SITOIGANAP CANCER
Glioma
NHS ENGLAND
SODIUM BENZOATE UREA CYCLE DISORDERS NHS ENGLAND
SODIUM HYDROXYBUTYRATE UREA CYCLE DISORDERS NHS ENGLAND
SODIUM OXYBATE NARCOLEPSY - PAEDIATRICS NHS ENGLAND
SODIUM PHENYLBUTYRATE UREA CYCLE DISORDERS NHS ENGLAND
SODIUM THIOSULFATE PREVENTION OF HEARING LOSS SECONDARY TO CISPLATIN CHEMOTHERAPY IN CHILDREN NHS ENGLAND
SOFOSBUVIR + LEDIPASVIR +/- RIBAVIRIN HEPATITIS C NHS ENGLAND
SOFOSBUVIR + PEGINTERFERON + RIBAVIRIN HEPATITIS C NHS ENGLAND
SOFOSBUVIR + VELPATASVIR HEPATITIS C NHS ENGLAND
SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR HEPATITIS C NHS ENGLAND
Somatrogon (Ngenla®) Growth Failure ICB
SORAFENIB CANCER
AML
NHS ENGLAND
SORAFENIB CANCER
Hepatocellular carcinoma
NHS ENGLAND
SORAFENIB CANCER
Thyroid cancer
NHS ENGLAND
SOTATERCEPT PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
SOTORASIB CANCER
Lung cancer
CDF
Sotrivimab (Xevudy®) Covid-19 ICB
STAVUDINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
STRIMVELIS
AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA cDNA SEQUENCE
ADENOSINE DEAMINASE DEFICIENCY-SEVERE COMBINED IMMUNODEFICIENCY  NHS ENGLAND
SUCROFERRIC OXYHYDROXIDE ADULT RENAL DIALYSIS ONLY NHS ENGLAND
SUNITINIB CANCER
Gastrointestinal stromal tumour
NHS ENGLAND
SUNITINIB CANCER
Neuroendocrine tumour
NHS ENGLAND
SUNITINIB CANCER
Renal cell carcinoma
NHS ENGLAND
SUSOCTOCOG ALFA
(FACTOR VIII - porcine recombinant)
ACQUIRED HAEMOPHILIA A NHS ENGLAND
SUTIMLIMAB PRIMARY COLD AGGLUTININ DISEASE NHS ENGLAND
TABELECLEUCEL CANCER
Posttransplant lymphoproliferative disorder
NHS ENGLAND
TACROLIMUS KIDNEY TRANSPLANT - ADULTS NHS ENGLAND
TACROLIMUS KIDNEY TRANSPLANT - CHILDREN & YOUNG PEOPLE NHS ENGLAND
TACROLIMUS TRANSPLANT IMMUNOSUPPRESSION ONLY NHS ENGLAND
TADALAFIL PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
TADALAFIL PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
TAFAMIDIS AMYLOIDOSIS NHS ENGLAND
TAFASITAMAB CANCER
B-cell lymphoma
NHS ENGLAND
TAGRAXOFUSP CANCER
Dendritic cell neoplasm
NHS ENGLAND
TALAZOPARIB CANCER
Breast cancer
NHS ENGLAND
TALAZOPARIB CANCER
Prostate cancer
NHS ENGLAND
TALIMOGENE LAHERPAREPVEC CANCER
Melanoma
NHS ENGLAND
Targeted-release budesonide (Kinpeygo®) Primary IgA nephropathy ICB
TASONERMIN CANCER NHS ENGLAND
TEBENTAFUSP CANCER
Uveal melanoma
CDF
TECLISTAMAB CANCER
MM
CDF
TECLISTAMAB CANCER
MM
NHS ENGLAND
TEDUGLUTIDE SHORT BOWEL SYNDROME NHS ENGLAND
TELBIVUDINE HEPATITIS B NHS ENGLAND
TELOTRISTAT CARCINOID SYNDROME DIARRHOEA NHS ENGLAND
TEMOZOLOMIDE CANCER
Astrocytoma
NHS ENGLAND
TEMOZOLOMIDE CANCER
Glioma
NHS ENGLAND
TEMOZOLOMIDE CANCER
Glioma
NHS ENGLAND
TEMOZOLOMIDE ENDOCRINOLOGY; NON-MALIGNANT CONDITIONS NHS ENGLAND
TEMSIROLIMUS CANCER
Renal cell carcinoma
NHS ENGLAND
TENOFOVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR ALAFENAMIDE HEPATITIS B NHS ENGLAND
TENOFOVIR ALAFENAMIDE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR ALAFENAMIDE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR ALAFENAMIDE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR ALAFENAMIDE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR ALAFENAMIDE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR DISOPROXIL HEPATITIS B +/- OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR DISOPROXIL HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR DISOPROXIL HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TENOFOVIR DISOPROXIL HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TEPOTINIB CANCER
Lung cancer
NHS ENGLAND
TEPRASIRAN PREVENTION OF DELAYED GRAFT FUNCTION NHS ENGLAND
TEPROTUMUMAB  GRAVES ORBITOPATHY NHS ENGLAND
TERIFLUNOMIDE MULTIPLE SCLEROSIS NHS ENGLAND
TERIFLUNOMIDE MULTIPLE SCLEROSIS NHS ENGLAND
TEZACAFTOR + IVACAFTOR CYSTIC FIBROSIS NHS ENGLAND
TEZACAFTOR + IVACAFTOR CYSTIC FIBROSIS NHS ENGLAND
TEZEPELUMAB ASTHMA NHS ENGLAND
THALIDOMIDE CANCER
MM
NHS ENGLAND
THROMBOMODULIN, RECOMBINANT HUMAN PSEUDOANEURYSM NHS ENGLAND
TIDEGLUSIB CONGENITAL MYOTONIC DYSTROPHY NHS ENGLAND
Tildrakizumab (Ilumetri®) Moderate to severe plaque psoriasis ICB
TIPRANAVIR HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
TISAGENLECLEUCEL  CANCER
ALL
NHS ENGLAND
TISAGENLECLEUCEL  CANCER
B-cell lymphoma
NHS ENGLAND
TIVOZANIB CANCER
Renal cell carcinoma
NHS ENGLAND
TOBRAMYCIN CYSTIC FIBROSIS NHS ENGLAND
TOBRAMYCIN CYSTIC FIBROSIS NHS ENGLAND
TOCILIZUMAB  ADULT ONSET STILLS DISEASE NHS ENGLAND
TOCILIZUMAB  CASTLEMAN'S DISEASE NHS ENGLAND
TOCILIZUMAB  CYTOKINE RELEASE SYNDROME FOLLOWING CAR-T OR BISPECIFIC ANTIBODY TREATMENT NHS ENGLAND
TOCILIZUMAB  GIANT CELL ARTERITIS NHS ENGLAND
TOCILIZUMAB  JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
TOCILIZUMAB  JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
TOCILIZUMAB  TAKAYASU ARTERITIS NHS ENGLAND
Tocilizumab (Tyenne®, RoActemra®) Covid-19 ICB
Tocilizumab (Tyenne®, RoActemra®) Rheumatoid Arthritis ICB
Tocilizumab (Tyenne®, RoActemra®) Juvenile arthritis (adult) ICB
TOFACITINIB JUVENILE IDIOPATHIC ARTHRITIS - PAEDIATRICS NHS ENGLAND
Tofacitinib (Xeljanz®) Rheumatoid Arthritis ICB
Tofacitinib (Xeljanz®) Psoriatic Arthritis ICB
Tofacitinib (Xeljanz®) Moderately to severe ulceratve colitis ICB
Tofacitinib (Xeljanz®) Ankylosing spondylitis ICB
Tofacitinib (Xeljanz®) Juvenile Idiopathic arthritis (adult only)  ICB
TOFERSEN SODIUM  AMYOTROPHIC LATERAL SCLEROSIS (MOTOR NEURONE DISEASE) NHS ENGLAND
TOLVAPTAN HYPONATRAEMIA IN  CANCER NHS ENGLAND
Tolvaptan (Samsca®) Autosomal dominant polycystic kidney disease ICB
TORIPALIMAB CANCER
Oesophageal cancer
NHS ENGLAND
TRABECTEDIN CANCER
Sarcoma
NHS ENGLAND
TRALOKINUMAB    ASTHMA NHS ENGLAND
Tralokinumab (Adtralza®) Moderate to severe atopic dermatitis ICB
TRAMETINIB CANCER
Glioma
NHS ENGLAND
TRAMETINIB CANCER
Lung cancer
NHS ENGLAND
TRAMETINIB CANCER
Melanoma
NHS ENGLAND
TRAMETINIB CANCER
Melanoma
NHS ENGLAND
TRAMETINIB CANCER
Ovarian cancer
NHS ENGLAND
TRAMETINIB CANCER
Thyroid cancer
NHS ENGLAND
TRASTUZUMAB   CANCER
Breast cancer
NHS ENGLAND
TRASTUZUMAB   CANCER
Breast cancer
NHS ENGLAND
TRASTUZUMAB   CANCER
Breast cancer
NHS ENGLAND
TRASTUZUMAB   CANCER
Gastric cancer
NHS ENGLAND
TRASTUZUMAB DERUXTECAN CANCER
Breast cancer
CDF
TRASTUZUMAB DERUXTECAN CANCER
Breast cancer
NHS ENGLAND
TRASTUZUMAB DERUXTECAN CANCER
Gastric or gastro-esophageal junction cancer
NHS ENGLAND
TRASTUZUMAB EMTANSINE CANCER
Breast cancer
NHS ENGLAND
TRASTUZUMAB EMTANSINE CANCER
Breast cancer
NHS ENGLAND
TREOSULFAN CANCER NHS ENGLAND
TREPROSTINIL SODIUM PULMONARY ARTERIAL HYPERTENSION NHS ENGLAND
TRIENTINE WILSONS DISEASE NHS ENGLAND
TRIFLURIDINE-TIPIRACIL CANCER
Colorectal cancer
NHS ENGLAND
TRIFLURIDINE-TIPIRACIL CANCER
Colorectal cancer
NHS ENGLAND
TRIFLURIDINE-TIPIRACIL CANCER
Gastric or gastro-oesophageal adenocarcinoma
NHS ENGLAND
TRIHEPTANOIN PYRUVATE CARBOXYLASE DEFICIENCY NHS ENGLAND
TUCATINIB CANCER
Breast cancer
NHS ENGLAND
TUROCTOCOG ALFA
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
TUROCTOCOG ALFA PEGOL
(FACTOR VIII - recombinant)
HAEMOPHILIA A NHS ENGLAND
UBLITUXIMAB MULTIPLE SCLEROSIS IMF
UBLITUXIMAB MULTIPLE SCLEROSIS NHS ENGLAND
UPADACITINIB MODERATE TO SEVERE ATOPIC DERMATITIS - PAEDIATRICS NHS ENGLAND
Upadacitinib (Rinvoq®) Crohn's disease ICB
Upadacitinib (Rinvoq®) Ulcerative Colitis ICB
Upadacitinib (Rinvoq®) Non-radiographic axial spondyloarthritis ICB
Upadacitinib (Rinvoq®) Moderate to severe atopic dermatitis ICB
Upadacitinib (Rinvoq®) Ankylosing spondylitis ICB
Upadacitinib (Rinvoq®) Psoriatic Arthritis ICB
Upadacitinib (Rinvoq®) Rheumatoid Arthritis ICB
URIDINE TRIACETATE TREATMENT OF TOXICITY WITH 5-FU AND CAPECITABINE NHS ENGLAND
USTEKINUMAB CROHN'S DISEASE - REFRACTORY IN PRE-PUBESCENT CHILDREN - PAEDIATRICS NHS ENGLAND
USTEKINUMAB PLAQUE PSORIASIS - PAEDIATRICS NHS ENGLAND
Ustekinumab (Pyzchiva ®, Uzpruvo® ,Stelara®) Psoriasis ICB
Ustekinumab (Pyzchiva ®, Uzpruvo® ,Stelara®) Psoriatic Arthritis ICB
Ustekinumab (Pyzchiva ®, Uzpruvo® ,Stelara®) Crohn’s disease ICB
Ustekinumab (Pyzchiva ®, Uzpruvo® ,Stelara®) Ulcerative Colitis (moderate to severe) ICB
VADADUSTAT   DIALYSIS-INDUCED ANAEMIA NHS ENGLAND
VALOCTOCOGENE ROXAPARVOVEC HAEMOPHILIA A NHS ENGLAND
VAMOROLONE DUCHENNE MUSCULAR DYSTROPHY NHS ENGLAND
VANDETANIB CANCER
Thyroid cancer
NHS ENGLAND
VATIQUINONE FRIEDREICHS ATAXIA NHS ENGLAND
VEDOLIZUMAB ULCERATIVE COLITIS - REFRACTORY IN PRE-PUBESCENT CHILDREN - PAEDIATRICS NHS ENGLAND
Vedolizumab (Entyvio®) Ulcerative Colitis (moderate to severe) ICB
Vedolizumab (Entyvio®) Crohn’s disease ICB
VELAGLUCERASE ALFA GAUCHER'S DISEASE NHS ENGLAND
VELMANASE ALFA ALPHA MANNOSIDASE DEFICIENCY NHS ENGLAND
VEMURAFENIB CANCER
Melanoma
NHS ENGLAND
VENETOCLAX CANCER
CLL
NHS ENGLAND
VENETOCLAX CANCER
AML
NHS ENGLAND
VENETOCLAX CANCER
AML
NHS ENGLAND
VENETOCLAX CANCER
CLL
NHS ENGLAND
VENETOCLAX CANCER
CLL
NHS ENGLAND
VENETOCLAX CANCER
CLL
NHS ENGLAND
Verteporfin (Visudyne®) Central serous chorioretinopathy ICB
Verteporfin (Visudyne®) Polypoidal choroidal vasculopathy ICB
VESTRONIDASE ALFA MUCOPOLYSACCHARIDOSIS VII NHS ENGLAND
VISMODEGIB CANCER
Basal cell carcinoma
NHS ENGLAND
VOCLOSPORIN LUPUS NEPHRITIS NHS ENGLAND
VOLANESORSEN FAMILIAL CHYLOMICRONEMIA SYNDROME NHS ENGLAND
VON WILLEBRAND FACTOR
(VON WILLEBRAND FACTOR - plasma derived)
VON WILLEBRAND DEFICIENCY NHS ENGLAND
VONICOG ALFA
(VON WILLEBRAND FACTOR - recombinant)
VON WILLEBRAND DEFICIENCY NHS ENGLAND
VORETIGENE NEPARVOVEC INHERITED RETINAL DISORDER NHS ENGLAND
VORICONAZOLE CHRONIC PULMONARY ASPERGILLOSIS NHS ENGLAND
VORICONAZOLE FUNGAL INFECTION NHS ENGLAND
VUTRISIRAN AMYLOIDOSIS NHS ENGLAND
ZANUBRUTINIB CANCER
Waldenstrom's macroglobulinaemia
NHS ENGLAND
ZANUBRUTINIB CANCER
CLL
NHS ENGLAND
ZANUBRUTINIB CANCER
Lymphoma
NHS ENGLAND
ZIDOVUDINE HIV IN COMBINATION WITH OTHER ANTI-RETROVIRAL DRUGS NHS ENGLAND
ZILUCOPLAN MYASTHENIA GRAVIS NHS ENGLAND
     
     
     
     
     
     
  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •